{"nct_id":"NCT05111249","title":"A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington's Disease","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2021-12-08","start_date_type":"ACTUAL","primary_completion_date":"2023-10-27","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}